- Metabolic Risk Profile and Cancer in Korean Men and Women
-
Seulki Ko, Seok-Jun Yoon, Dongwoo Kim, A-Rim Kim, Eun-Jung Kim, Hye-Young Seo
-
J Prev Med Public Health. 2016;49(3):143-152. Published online May 18, 2016
-
DOI: https://doi.org/10.3961/jpmph.16.021
-
-
12,713
View
-
290
Download
-
39
Crossref
-
 Abstract
 PDF
- Objectives
Metabolic syndrome is a cluster of risk factors for type 2 diabetes mellitus and cardiovascular disease. Associations between metabolic syndrome and several types of cancer have recently been documented.
Methods
We analyzed the sample cohort data from the Korean National Health Insurance Service from 2002, with a follow-up period extending to 2013. The cohort data included 99 565 individuals who participated in the health examination program and whose data were therefore present in the cohort database. The metabolic risk profile of each participant was assessed based on obesity, high serum glucose and total cholesterol levels, and high blood pressure. The occurrence of cancer was identified using Korean National Health Insurance claims data. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models, adjusting for age group, smoking status, alcohol intake, and regular exercise.
Results
A total of 5937 cases of cancer occurred during a mean follow-up period of 10.4 years. In men with a high-risk metabolic profile, the risk of colon cancer was elevated (HR, 1.40; 95% CI, 1.14 to 1.71). In women, a high-risk metabolic profile was associated with a significantly increased risk of gallbladder and biliary tract cancer (HR, 2.05; 95% CI, 1.24 to 3.42). Non-significantly increased risks were observed in men for pharynx, larynx, rectum, and kidney cancer, and in women for colon, liver, breast, and ovarian cancer.
Conclusions
The findings of this study support the previously suggested association between metabolic syndrome and the risk of several cancers. A high-risk metabolic profile may be an important risk factor for colon cancer in Korean men and gallbladder and biliary tract cancer in Korean women.
-
Summary
-
Citations
Citations to this article as recorded by  - Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis
Yanyu Zhou, Yujun Chen, Heng Yang, Zhiqi Xu, Jinbiao Zhuang, Qitao Bian, Gongxian Wang
BMC Nephrology.2025;[Epub] CrossRef - Association of Metabolic Syndrome With Risk of Lung Cancer
Mengmeng Li, Su-Mei Cao, Niki Dimou, Lan Wu, Ji-Bin Li, Jun Yang
CHEST.2024; 165(1): 213. CrossRef - Association between insulin resistance, metabolic syndrome and its components and lung cancer: a systematic review and meta-analysis
Jingxuan Liu, Rui Wang, Song Tan, Xiaohu Zhao, Aihua Hou
Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef - Association between metabolic syndrome and kidney cancer risk: a prospective cohort study
Lin Wang, Han Du, Chao Sheng, Hongji Dai, Kexin Chen
Lipids in Health and Disease.2024;[Epub] CrossRef - Interplay of Cardiometabolic Syndrome and Biliary Tract Cancer: A Comprehensive Analysis with Gender-Specific Insights
Vincenza Di Stasi, Antonella Contaldo, Lucia Birtolo, Endrit Shahini
Cancers.2024; 16(19): 3432. CrossRef - Survival benefit of metformin use according to cancer diagnosis in diabetic patients with metabolic syndrome
Ji Soo Park, Soo Jin Moon, Hyung Seok Park, Sang-Hoon Cho
Preventive Medicine Reports.2024; 48: 102928. CrossRef - Metabolic syndrome and risk of ovarian cancer: a systematic review and meta-analysis
Ziyu Chen, Zesi Liu, Hongxia Yang, Chaosheng Liu, Fandou Kong
Frontiers in Endocrinology.2023;[Epub] CrossRef - Updated epidemiology of gastrointestinal cancers in East Asia
Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong
Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271. CrossRef - Association of metabolic syndrome and its components with the risk of kidney cancer: A cohort-based case-control study
Runxue Jiang, Zhi Li, Xia Wang, Haifeng Cai, Shouling Wu, Shuohua Chen, Hailong Hu
Technology and Health Care.2023; 31(4): 1235. CrossRef - Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees Study
Dan Huang, Woo-Kyoung Shin, Katherine De la Torre, Hwi-Won Lee, Sukhong Min, Aesun Shin, Jong-Koo Lee, Daehee Kang
Gastric Cancer.2023; 26(4): 481. CrossRef - Association Between Metabolic Syndrome and the Risk of Lung Cancer: A
Meta-Analysis
Zhao Zhang, Qinxiang Liu, Congcong Huang, Jun Wu, Yingsheng Wen
Hormone and Metabolic Research.2023; 55(12): 846. CrossRef - The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study
Yu-Guang Chen, Chih-Wei Yang, Chi-Hsiang Chung, Ching-Liang Ho, Wei-Liang Chen, Wu-Chien Chien
Hepatology International.2022; 16(4): 807. CrossRef - The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study
Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu
Frontiers in Oncology.2022;[Epub] CrossRef - Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis
Morgan Connaughton, Mahsa Dabagh
Healthcare.2022; 10(6): 1074. CrossRef - Association Between Metabolic Syndrome and Risk of Renal Cell Cancer: A Meta-Analysis
Wurong Du, Kaibo Guo, Huimin Jin, Leitao Sun, Shanming Ruan, Qiaoling Song
Frontiers in Oncology.2022;[Epub] CrossRef - The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study
Seong-geun Moon, Boyoung Park
Journal of Preventive Medicine and Public Health.2022; 55(5): 475. CrossRef - The association between hypertension and colorectal cancer: a meta-analysis of observational studies
Kun Xuan, Tianming Zhao, Chenyu Sun, Akash S. Patel, Haixia Liu, Xin Chen, Guangbo Qu, Yehuan Sun
European Journal of Cancer Prevention.2021; 30(1): 84. CrossRef - Metabolic syndrome and esophageal cancer risk: a systematic review and meta‑analysis
Jinjia Zhang, Huadong Wu, Rongying Wang
Diabetology & Metabolic Syndrome.2021;[Epub] CrossRef - Metabolic syndrome and gastric cancer risk: a systematic review and meta-analysis
Marco Mariani, Michele Sassano, Stefania Boccia
European Journal of Cancer Prevention.2021; 30(3): 239. CrossRef - Persistent status of metabolic syndrome and risk of cholangiocarcinoma: A Korean nationwide population-based cohort study
Joo-Hyun Park, Jung Y. Hong, Young S. Park, Gunseog Kang, Kyungdo Han, Joon O. Park
European Journal of Cancer.2021; 155: 97. CrossRef - Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis
Xiaoding Shen, Yong Wang, Rui Zhao, Qianyi Wan, Yutao Wu, Lihao Zhao, Xiaoting Wu
International Journal of Colorectal Disease.2021; 36(10): 2215. CrossRef - Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study
Bin Xia, Jianjun Peng, De Toni Enrico, Kuiqing Lu, Eddie C. Cheung, Zichong Kuo, Qiangsheng He, Yan Tang, Anran Liu, Die Fan, Changhua Zhang, Yulong He, Yihang Pan, Jinqiu Yuan
BMC Cancer.2021;[Epub] CrossRef - Association between Abdominal Obesity and Incident Colorectal Cancer: A Nationwide Cohort Study in Korea
Ga Eun Nam, Se-Jin Baek, Hong Bae Choi, Kyungdo Han, Jung-Myun Kwak, Jin Kim, Seon-Hahn Kim
Cancers.2020; 12(6): 1368. CrossRef - Metabolic Syndrome and Risk of Lung Cancer: An Analysis of Korean National Health Insurance Corporation Database
Sooim Sin, Chang-Hoon Lee, Sun Mi Choi, Kyung-Do Han, Jinwoo Lee
The Journal of Clinical Endocrinology & Metabolism.2020; 105(11): e4102. CrossRef - Metabolic syndrome and the incidence of lung cancer: a meta-analysis of cohort studies
Li Qiao, Deliang Ma, Hui Lv, Ding Shi, Min Fei, Yu Chen, Fei Xie, Zhuoyan Wang, Ying Wang, Wanhua Liang, Peiying Hu
Diabetology & Metabolic Syndrome.2020;[Epub] CrossRef - Metabolic Syndrome and Colorectal Cancer Risk: Results of Propensity Score-Based Analyses in a Community-Based Cohort Study
Jinsun Kim, Eun Young Park, Eunjung Park, Min Kyung Lim, Jin-Kyoung Oh, Byungmi Kim
International Journal of Environmental Research and Public Health.2020; 17(22): 8687. CrossRef - The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis
Ping Zhao, Ning Xia, Hong Zhang, Tingting Deng
Obesity Facts.2020; 13(4): 384. CrossRef - Metabolic syndrome and liver-related events: a systematic review and meta-analysis
Huina Ren, Junna Wang, Yue Gao, Fuwei Yang, Wenxiang Huang
BMC Endocrine Disorders.2019;[Epub] CrossRef - Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies
Aristeidis Seretis, Sofia Cividini, Georgios Markozannes, Xanthippi Tseretopoulou, David S. Lopez, Evangelia E. Ntzani, Konstantinos K. Tsilidis
Scientific Reports.2019;[Epub] CrossRef - Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER–Medicare data
Kara A. Michels, Timothy S. McNeel, Britton Trabert
Gynecologic Oncology.2019; 155(2): 294. CrossRef - Association between metabolic syndrome and the incidence of gastric cancer: a meta-analysis of cohort studies
Zhibin Li, Hongfeng Han, Yuan Chang
Diabetology & Metabolic Syndrome.2019;[Epub] CrossRef - Association Between Metabolic Syndrome and Breast Cancer Risk: An Updated Meta-Analysis of Follow-Up Studies
Meng Guo, Tingting Liu, Peiting Li, Tianying Wang, Chen Zeng, Meng Yang, Gang Li, Jiang Han, Wei Wu, Ruopeng Zhang
Frontiers in Oncology.2019;[Epub] CrossRef - Incidence of Colon Cancer Related to Cigarette Smoking and Alcohol Consumption in Adults with Metabolic Syndrome: Prospective Cohort Study
Ahra Jo, Heeyoung Oh
Journal of Korean Academy of Nursing.2019; 49(6): 713. CrossRef - Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors)
Natalia V. Yunusova, Irina V. Kondakova, Larisa A. Kolomiets, Sergey G. Afanas'ev, Alena L. Chernyshova, Igor V. Kudryavtsev, Anastasia A. Tsydenova
Asia-Pacific Journal of Clinical Oncology.2018; 14(3): 134. CrossRef - Incidence and risk factors of colorectal cancer based on 56 324 health checkups: A 7‐year retrospective cohort study
Toshiko Fujii, Masayuki Ohisa, Toru Sako, Takayuki Harakawa, Kazuaki Sakamune, Shintaro Nagashima, Aya Sugiyama, Yuichiro Matsuura, Junko Tanaka
Journal of Gastroenterology and Hepatology.2018; 33(4): 855. CrossRef - The role of metabolic syndrome variant in the malignant tumors progression
Natalia V. Yunusova, Irina V. Kondakova, Larisa A. Kolomiets, Sergey G. Afanas’ev, Anastasia Yu. Kishkina, Liudmila V. Spirina
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2018; 12(5): 807. CrossRef - Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients
Alban Zarzavadjian Le Bian, Christine Denet, Nicolas Tabchouri, Gianfranco Donatelli, Philippe Wind, Christophe Louvet, Mostefa Bennamoun, Christos Christidis, Thierry Perniceni, David Fuks, Brice Gayet
Langenbeck's Archives of Surgery.2018; 403(4): 443. CrossRef - Effect of Work-Related Sedentary Time on Overall Health Profile in Active vs. Inactive Office Workers
Pauline M. Genin, Pascal Dessenne, Julien Finaud, Bruno Pereira, Frederic Dutheil, David Thivel, Martine Duclos
Frontiers in Public Health.2018;[Epub] CrossRef - A Case of Endoscopic Submucosal Dissection of Esophageal Adenocarcinoma Arising from Barrett's Esophagus
Joon Sung Kim, Byung-Wook Kim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2016; 16(3): 169. CrossRef
- The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
-
Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
-
J Prev Med Public Health. 2015;48(4):180-187. Published online July 20, 2015
-
DOI: https://doi.org/10.3961/jpmph.15.022
-
-
10,389
View
-
117
Download
-
14
Crossref
-
Abstract
PDF
- Objectives
Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea.
Methods
We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers’ costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death.
Results
In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively.
Conclusions
We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.
-
Summary
-
Citations
Citations to this article as recorded by
- Economic Burden of Colorectal Cancer in Korea
-
Ju-Young Byun, Seok-Jun Yoon, In-Hwan Oh, Young Ae Kim, Hye-Young Seo, Yo-Han Lee
-
J Prev Med Public Health. 2014;47(2):84-93. Published online March 31, 2014
-
DOI: https://doi.org/10.3961/jpmph.2014.47.2.84
-
-
15,936
View
-
151
Download
-
18
Crossref
-
Abstract
PDF
- Objectives
The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service. MethodsEconomic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs. ResultsThe prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively. ConclusionsColorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.
-
Summary
-
Citations
Citations to this article as recorded by - Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis
Hong Wang, Yan‐Jie Li, Lin Lei, Cheng‐Cheng Liu, Wan‐Qing Chen, Min Dai, Xin Wang, Jie‐Bin Lew, Ju‐Fang Shi, Ni Li, Jie He
Cancer Medicine.2024;[Epub] CrossRef - Relationship Between Aspirin Use and Site-Specific Colorectal Cancer Risk Among Individuals With Metabolic Comorbidity
Seokyung An, Madhawa Gunathilake, Jeonghee Lee, Minji Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
Journal of Korean Medical Science.2024;[Epub] CrossRef - Cost of illness for colorectal cancer in Japan - a time trend and future projections (1996–2035) based on governmental statistics
Kunichika Matsumoto, Yosuke Hatakeyama, Kanako Seto, Ryo Onishi, Koki Hirata, Yinghui Wu, Tomonori Hasegawa
BMC Health Services Research.2023;[Epub] CrossRef - Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
Bander Balkhi, Ahmed Alghamdi, Saeed Alqahtani, Marwan Al Najjar, Abdullah Al Harbi, Thamer Bin Traiki
Saudi Pharmaceutical Journal.2023; 31(11): 101822. CrossRef - A performance measurement framework for socially sustainable and resilient supply chains using environmental goods valuation methods
Aref A. Hervani, Santosh Nandi, Marilyn M. Helms, Joseph Sarkis
Sustainable Production and Consumption.2022; 30: 31. CrossRef - Direct medical costs of young-onset colorectal cancer: a worldwide systematic review
Ria Garg, Vicki Cheng, Ursula Ellis, Vanay Verma, Helen McTaggart-Cowan, Stuart Peacock, Jonathan M. Loree, Mohsen Sadatsafavi, Mary A. De Vera
BMC Health Services Research.2022;[Epub] CrossRef - Economic Burden of Colorectal Cancer: A Case of Fars, Iran
Abdosaleh Jafari, Peyman Mehdi Alamdarloo, Mehdi Dehghani, Peivand Bastani, Ramin Ravangard
Cancer Control.2021;[Epub] CrossRef - Quality of life and costs of patients prior to colorectal surgery
M. Pattamatta, B. J. J. Smeets, S. M. A. A. Evers, E. G. Peters, M. D. P. Luyer, M. Hiligsmann
Expert Review of Pharmacoeconomics & Outcomes Research.2020; 20(2): 193. CrossRef - Socioeconomic Burden of Cancer in Korea from 2011 to 2015
Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
Cancer Research and Treatment.2020; 52(3): 896. CrossRef - The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective
Binh Thang Tran, Kui Son Choi, Thanh Xuan Nguyen, Dae Kyung Sohn, Sun-Young Kim, Jae Kyung Suh, Van Sang Phan, Huu Tri Pham, Minh Hanh Nguyen, Thanh Binh Nguyen, Huu Khoi Hoang, Thi Thanh Binh Nguyen, Minh Tu Nguyen, Jin-Kyoung Oh
International Journal of Environmental Research and Public Health.2020; 18(1): 12. CrossRef - Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study
In Cheol Hwang, Jooyoung Chang, Sang Min Park, Suminori Akiba
PLOS ONE.2017; 12(12): e0189114. CrossRef - Analysis of Productivity Costs in Cancer: A Systematic Review
Jordi Gol-Montserrat, María Luisa M. del Burgo, Luis Quecedo, Juan E. del Llano
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish.2017; 4(1): grhta.5000262. CrossRef - The Economic Burden of Hepatitis A, B, and C in South Korea
Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
Japanese Journal of Infectious Diseases.2016; 69(1): 18. CrossRef - Dehydroglyasperin D Inhibits the Proliferation of HT-29 Human Colorectal Cancer Cells Through Direct Interaction With Phosphatidylinositol 3-kinase
Sung Keun Jung, Chul-Ho Jeong
Journal of Cancer Prevention.2016; 21(1): 26. CrossRef - The Economic Burden of Cancer in Korea in 2009
So Young Kim, Jong-Hyock Park, Kyoung Hee Kang, Inuk Hwang, Hyung Kook Yang, Young-Joo Won, Hong-Gwan Seo, Dukhyoung Lee, Seok-Jun Yoon
Asian Pacific Journal of Cancer Prevention.2015; 16(3): 1295. CrossRef - The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
Journal of Preventive Medicine and Public Health.2015; 48(4): 180. CrossRef - Trends in Colorectal Cancer Incidence in Daejeon and Chungcheongnam-do, South Korea (2000-2012)
Soon-Young Kim, In-Sun Kweon, Jung-A Kim, Tae-Yong Lee, Hae-Sung Nam
Journal of agricultural medicine and community health.2015; 40(3): 115. CrossRef - FOXM1-mediated downregulation of uPA and MMP9 by 3,3′-diindolylmethane inhibits migration and invasion of human colorectal cancer cells
HUA JIN, XIU JUAN LI, MAN HEE PARK, SOO MI KIM
Oncology Reports.2015; 33(6): 3171. CrossRef
- The Economic Burden of Epilepsy in Korea, 2010
-
Jaehun Jung, Hye-Young Seo, Young Ae Kim, In-Hwan Oh, Yo Han Lee, Seok-Jun Yoon
-
J Prev Med Public Health. 2013;46(6):293-299. Published online November 28, 2013
-
DOI: https://doi.org/10.3961/jpmph.2013.46.6.293
-
-
11,074
View
-
131
Download
-
11
Crossref
-
Abstract
PDF
- Objectives
The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. MethodsThis study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. ResultsThe annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy. ConclusionsA significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.
-
Summary
-
Citations
Citations to this article as recorded by - Economic assessment of convulsive status epilepticus: Investigating socioeconomic correlations in hospitalization costs and outcomes in Northern India
Ahmad Ghayas Ansari, Ariba Nasar, Hiba Nasar
IP Indian Journal of Neurosciences.2024; 10(2): 78. CrossRef - Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea
Ji Woong Lee, Jung-Ae Kim, Min Young Kim, Sang Kun Lee
Epilepsy & Behavior.2022; 126: 108459. CrossRef - Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia
Piniel Melkamu, Yaregal Animut, Amare Minyihun, Asmamaw Atnafu, Mezgebu Yitayal
Risk Management and Healthcare Policy.2021; Volume 14: 2385. CrossRef - Cost–benefit analysis, cost-effectiveness analysis, and impact of antiepileptic drugs on the risk of fracture in patients with epilepsy: A nationwide cohort study
Hsin-Hsuan Cheng, Pei-Tseng Kung, Bo-Ren Wang, Li-Ting Chiu, Wen-Chen Tsai
Epilepsy & Behavior.2020; 103: 106851. CrossRef - Introducing big data analysis using data from National Health Insurance Service
EunJin Ahn
Korean Journal of Anesthesiology.2020; 73(3): 205. CrossRef - Epilepsy in Asia: Disease burden, management barriers, and challenges
Eugen Trinka, Patrick Kwan, ByungIn Lee, Amitabh Dash
Epilepsia.2019; 60(S1): 7. CrossRef - The Present and Future of Vagus Nerve Stimulation
Jeyul Yang, Ji Hoon Phi
Journal of Korean Neurosurgical Society.2019; 62(3): 344. CrossRef - Costs of informal nursing care for patients with neurologic disorders
Freya Diederich, Hans-Helmut König, Claudia Mietzner, Christian Brettschneider
Neurology.2018; 90(1): 28. CrossRef - The Economic Burden of Hepatitis A, B, and C in South Korea
Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
Japanese Journal of Infectious Diseases.2016; 69(1): 18. CrossRef - A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
The Spine Journal.2016; 16(8): 937. CrossRef - The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow
Alla Guekht, Maria Mizinova, Igor Kaimovsky, Oksana Danilenko, Elisa Bianchi, Ettore Beghi
Epilepsy & Behavior.2016; 64: 122. CrossRef
|
KSPM
